Table 2 Association of subphenotypes with ICU mortality and 28-day mortality.
28-day mortality | PL | SIL | NL | RDL | |||
|---|---|---|---|---|---|---|---|
HR (95%CI) | p | HR (95%CI) | p | HR (95%CI) | p | ||
(A) | |||||||
Derivation cohort | |||||||
Unadjusted | Reference | 0.61 (0.49–0.75) | < 0.001 | 0.55 (0.41–0.73) | < 0.001 | 0.86 (0.66–1.13) | 0.283 |
Adjusted | Reference | 0.71 (0.57–0.88) | 0.002 | 0.67 (0.50–0.89) | 0.005 | 0.92(0.70–1.20) | 0.520 |
External validation cohort | |||||||
Unadjusted | Reference | 0.46 (0.34–0.63) | < 0.001 | 0.26 (0.17–0.40) | < 0.001 | 0.65 (0.38–1.11) | 0.116 |
Adjusted | Reference | 0.52 (0.36–0.74) | < 0.001 | 0.34 (0.20–0.57) | < 0.001 | 0.61 (0.33–1.13) | 0.118 |
ICU mortality | PL | SIL | NL | RDL | |||
|---|---|---|---|---|---|---|---|
HR (95%CI) | p | HR (95%CI) | p | HR (95%CI) | p | ||
(B) | |||||||
Derivation cohort | |||||||
Unadjusted | Reference | 0.69 (0.56–0.86) | < 0.001 | 0.61 (0.46–0.82) | < 0.001 | 0.86 (0.65–1.14) | 0.313 |
Adjusted | Reference | 0.75 (0.61–0.94) | 0.012 | 0.76 (0.57–0.99) | 0.048 | 0.90 (0.68–1.20) | 0.491 |
External validation cohort | |||||||
Unadjusted | Reference | 0.62 (0.47–0.89) | 0.007 | 0.50 (0.33–0.77) | 0.001 | 0.70 (0.41–1.19) | 0.187 |
Adjusted | Reference | 0.62 (0.44–0.87) | 0.006 | 0.49 (0.30–0.80) | 0.004 | 0.64 (0.35–1.16) | 0.141 |